Best online GLP‑1 providers of 2026, ranked by what they disclose
We compared each online GLP-1 program beyond the checkout: complete cost, who reviews eligibility, medication status and pharmacy path, ongoing support, insurance, renewal, cancellation, and state availability.
B.A. Psychology, University of Washington · B.S. Computer Science, Oregon State University
Editorial Research: Taylor reviewed the primary sources, provider disclosures, and material claims cited on this page.He is a publisher and software engineer—not a clinician, pharmacist, or medical reviewer.
Source CheckSeptember 4th, 2026
17 independently source-checked records
The 2026 evidence ranking
Ordered by public evidence coverage—not clinical quality, safety, popularity, or expected weight loss. Current source checks are dated through September 4th, 2026.
17 providers shownFilters describe the ranked public path, not every treatment a company may offer.
Rank01
Best documented pharmacy choice
Lavender Sky Health
Direct pay · compounded and brand-name paths
Evidence97/100
Lavender Sky Health publishes the deepest price-and-pharmacy record in this comparison, including consult fees, plan lengths, pharmacy options, formulation notes, and state-by-state availability.
Published cost
$65 for a new-patient consult and $40 for a follow-up. The pricing page shows a $195 compounded semaglutide Tier 1 plan covering about 8–10 weeks; its standard brand-name path is $25 per month plus the medication cost.
A US-licensed clinician reviews the chart and may issue a prescription when appropriate. The provider describes itself as physician-owned and publishes required follow-up intervals.
The provider publishes both custom-compounded and standard brand-name paths, names pharmacy options, and states that compounded medications are not FDA-approved. Pharmacy and formulation availability varies by state.
Readers who want to compare a specific pharmacy, formulation, supply length, and direct-pay care fee before choosing a path.
What to confirm
The large number of pharmacy, dose, additive, and supply-length combinations makes the final all-in cost harder to summarize as one number.
View complete program record
Editorial readout · checked September 4th, 2026
What the public record shows
The documentation is unusually useful before checkout. The tradeoff is complexity: the final cost and formulation depend on the pharmacy, plan length, dose, and state, and Lavender Sky says it does not handle insurance claims or prior authorizations.
Evidence score breakdown
Cost clarity24/25
Clinical accountability19/20
Medication + pharmacy20/20
Ongoing support14/15
Terms + states10/10
Evidence freshness10/10
Remaining published terms
Ongoing support
Published plans include portal access and support from the healthcare provider and patient-support team until the next required follow-up.
Lavender Sky says it does not process insurance claims or prior authorizations. Consults are direct-pay, and medication is billed separately or included according to the selected plan.
The provider says it serves all 50 states and Washington, DC. Its state table shows that the available pharmacy and medication choices differ by location.
Rift publishes both compounded semaglutide and tirzepatide programs and a live tirzepatide selector with pharmacy-specific totals, formulations, state limits, and renewal terms.
Published cost
Semaglutide is $399 through Nova/WhiteLabel or $419 through Hallandale for 12 weeks. For tirzepatide, the live selector shows $499 for 12 weeks through Hallandale, Hyalo/NewLife, or Nova; $469 through Southend; or a $299 Drug Crafters promotion.
A licensed provider reviews the health information and determines whether to prescribe. Provider review and guidance are included; a prescription is not guaranteed.
Publishes compounded semaglutide and compounded tirzepatide paths. The tirzepatide selector names the available pharmacy, formulation or additive, and state restrictions for each choice. Compounded medications are not FDA-approved drug products.
Comparing named pharmacies, formulations, state rules, and upfront totals before intake
What to confirm
The lowest tirzepatide price is a time-limited Drug Crafters promotion; pharmacy and state eligibility change which price is available.
View complete program record
Editorial readout · checked September 4th, 2026
What the public record shows
The live selector makes the pharmacy choice unusually concrete before checkout. The lowest tirzepatide price is a time-limited Drug Crafters offer; standard Hallandale, Hyalo/NewLife, and Nova paths are $499 for 12 weeks, while Southend is $469.
Evidence score breakdown
Cost clarity25/25
Clinical accountability17/20
Medication + pharmacy20/20
Ongoing support14/15
Terms + states9/10
Evidence freshness10/10
Remaining published terms
Included care and support
Provider review, medication if prescribed, injection supplies, expedited shipping, and ongoing support are included in the compared programs.
Each enabled pharmacy choice publishes its own state rules. The Hyalo/NewLife tirzepatide path is shown across all 50 states, while Nova excludes California and other paths have narrower state lists.
Most compared choices are 12-week totals billed upfront and renew automatically unless paused or canceled in the patient portal. The $299 Drug Crafters tirzepatide promotion runs through December 31st, 2026 and renews at $349.
A licensed provider reviews the health information and determines whether to prescribe. Provider review and guidance are included; a prescription is not guaranteed.
Publishes compounded semaglutide and compounded tirzepatide paths. The tirzepatide selector names the available pharmacy, formulation or additive, and state restrictions for each choice.
The main compared paths cover 12 weeks, with a one-month Hallandale option also shown. Continued orders can be paused or canceled in the patient portal.
Big Easy Weight Loss publishes 12-week compounded-treatment prices, a named pharmacy roster, a named physician team, and a live-physician model with continued physician access.
Published cost
$75 consultation, credited toward treatment or refunded if the provider determines the patient is not a good fit. The site lists 12-week compounded semaglutide packages from $399 starter/$495 standard and tirzepatide from $499 starter/$599 standard.
Every treatment is described as including a live physician appointment and ongoing physician access. The site identifies its chief medical officer and a roster of physicians.
The published offers are compounded semaglutide and compounded tirzepatide. Big Easy names multiple 503A and 503B pharmacy partners and states that compounded drugs are not FDA-approved.
Readers who place a live physician appointment and continued physician access ahead of a fully asynchronous signup.
What to confirm
The exact pharmacy and formulation can vary, so the lowest headline price is not a complete patient-specific quote.
View complete program record
Editorial readout · checked September 4th, 2026
What the public record shows
The strongest public evidence is the clearly stated physician appointment and the pharmacy roster. Readers should still confirm the exact pharmacy, formulation, turnaround, and renewal cost because those details vary and the current pricing page contains more than one turnaround estimate.
Evidence score breakdown
Cost clarity23/25
Clinical accountability20/20
Medication + pharmacy19/20
Ongoing support13/15
Terms + states9/10
Evidence freshness10/10
Remaining published terms
Ongoing support
The provider says treatment includes access to the physician for the duration of care, supplies, and shipping.
Big Easy says it serves all 50 states. The pricing flow asks for a state because treatment and pharmacy availability still vary by location and eligibility.
Published GLP-1 offers cover 12 weeks. Monthly installments are advertised, but readers should confirm the payment and renewal schedule before enrolling.
Trimi publishes complete semaglutide and tirzepatide plan totals, a month-to-month exit path, same-price-at-every-dose terms, two named 503A pharmacies, and its clinical network.
Published cost
Semaglutide is $175 monthly, $435 quarterly, $720 for six months, or $1,188 annually. Tirzepatide is $235 monthly, $597 quarterly, $1,050 for six months, or $1,500 annually.
A US-licensed provider through Arora Health reviews the online visit and decides whether to prescribe. Portal support and dose-review access are included.
Publishes compounded semaglutide and tirzepatide prepared for individual prescriptions by VialsRx or GreenwichRx, both identified as US 503A sterile compounding pharmacies. Compounded medications are not FDA-approved drug products.
Named 503A pharmacies plus flexible monthly and discounted multi-month choices
What to confirm
Official pages describe multi-month billing differently; get the amount charged today and the cancellation effect in writing.
View complete program record
Editorial readout · checked September 4th, 2026
What the public record shows
The public pages make cash due, medication status, clinician review, named pharmacies, and support easy to compare. Longer plans cost less per month but require substantially more cash and commitment than the headline monthly equivalent suggests.
Evidence score breakdown
Cost clarity24/25
Clinical accountability17/20
Medication + pharmacy20/20
Ongoing support14/15
Terms + states8/10
Evidence freshness10/10
Remaining published terms
Included care and support
Medication if prescribed, online consultation, supplies, care-team access, a patient portal, and expedited shipping are included.
Month-to-month choices are $175 for semaglutide and $235 for tirzepatide. Lower monthly equivalents use three-, six-, or 12-month terms; the pricing and refund pages describe their billing timing differently, so confirm the actual charge schedule.
A US-licensed provider through Arora Health reviews the online visit and decides whether to prescribe. Portal support and dose-review access are included.
Publishes compounded semaglutide and tirzepatide prepared for individual prescriptions by VialsRx or GreenwichRx, both identified as US 503A sterile compounding pharmacies.
Trillium's live offer matrix covers compounded semaglutide and tirzepatide with package totals, pharmacies, formulations, beyond-use dates, carriers, and state coverage.
Published cost
The live matrix lists semaglutide at $159 for one month, $257 for a three-month starter, or $357 for a three-month any-dose plan. Tirzepatide examples include $199 for one month and $399 or $499 for three months through Hyalo/NewLife; other pharmacies vary.
Wasef Health clinicians review asynchronous intake, generally in one to three business days. Several jurisdictions require a synchronous visit, and portal messaging is available.
The live matrix publishes compounded semaglutide and tirzepatide choices and identifies the marketing pharmacy, fulfillment pharmacy, formulation, beyond-use date, carrier, and state list for each offer. Compounded medications are not FDA-approved drug products.
Comparing package totals, formulations, pharmacies, BUDs, carriers, and state coverage
What to confirm
The menu is detailed but complex: medication, dose, pharmacy, formulation, state, and supply length can all change the comparison.
View complete program record
Editorial readout · checked September 4th, 2026
What the public record shows
This is one of the deepest pharmacy-level offer records in the comparison. The exact value depends on medication, dose, pharmacy, formulation, state, supply length, and whether the selected plan recurs.
Evidence score breakdown
Cost clarity24/25
Clinical accountability17/20
Medication + pharmacy20/20
Ongoing support13/15
Terms + states8/10
Evidence freshness10/10
Remaining published terms
Included care and support
Clinician review, medication if prescribed, standard shipping, and portal messaging are included; payment is captured after a prescription is issued.
The clinical network covers all 50 states and Puerto Rico. Each pharmacy offer has its own state list, and current Hyalo/NewLife and VialsRx paths show all 50 states.
One- and three-month packages are published. Trillium describes the service as subscription-based with the ability to pause; verify the recurrence and cancellation cutoff for the exact selected offer.
Wasef Health clinicians review asynchronous intake, generally in one to three business days. Several jurisdictions require a synchronous visit, and portal messaging is available.
The live matrix publishes compounded semaglutide and tirzepatide choices and identifies the marketing pharmacy, fulfillment pharmacy, formulation, beyond-use date, carrier, and state list for each offer.
Ro publishes separate membership and medication prices, multiple commitment lengths, dose-level cash prices, and a detailed insurance-navigation workflow.
Published cost
$39 for the first membership month, then $74–$149 per month depending on commitment and prepayment. Medication is separate; the pricing page publishes current cash prices by medication and dose, starting at $149 for selected options.
A Ro-affiliated provider reviews the online visit, determines eligibility, and may request metabolic lab testing. Ongoing provider messaging and check-ins are part of the membership.
Ro lists multiple FDA-approved oral and injectable brand-name options. Depending on the prescription and payment path, medication may ship from Ro or a partner pharmacy or be sent to the patient's preferred pharmacy.
Readers comparing FDA-approved brand-name options who want published cash prices plus prior-authorization and insurance-navigation help.
What to confirm
The cheapest membership rate requires twelve-month prepayment; the month-to-month rate is higher.
View complete program record
Editorial readout · checked September 4th, 2026
What the public record shows
Ro's public pages make the two-charge structure unusually clear: the Body membership pays for care and support, while medication is billed separately. The lowest recurring membership price requires annual prepayment, and medication price still depends on the prescription, dose, insurance, and payment plan.
Evidence score breakdown
Cost clarity25/25
Clinical accountability16/20
Medication + pharmacy17/20
Ongoing support15/15
Terms + states8/10
Evidence freshness10/10
Remaining published terms
Ongoing support
The membership includes provider messaging, regular check-ins, coaching, dose and side-effect support, insurance concierge services, and labs when necessary.
Ro's concierge checks coverage and handles prior-authorization paperwork for eligible medications. Coverage is not guaranteed, and insurance does not cover the Ro Body membership.
Medication and state availability vary. Ro publishes additional eligibility limits for certain government-insurance beneficiaries and distinguishes cash-pay from insurance-supported options.
The public workflow identifies Ro-affiliated providers but provides less individual clinician detail at the decision point than the highest-scoring records.
OLA publishes a manual-reorder compounded tirzepatide menu with pharmacy, formulation, dose, state, and one- or three-month pricing choices.
Published cost
Compounded tirzepatide options start at $129 month to month or $289 for a 12-week starter through Drug Crafters where available; other current pharmacy paths range from $149 to $189 monthly or $349 to $389 for 12 weeks.
Publishes compounded tirzepatide paths through Drug Crafters, ReviveRx, Mountain Care, White Label/Nova, and New Life/Hyalo, with formulation and state notes. Compounded medications are not FDA-approved drug products.
A manual-reorder tirzepatide plan with named pharmacy and formulation choices
What to confirm
The lowest price is limited by pharmacy, state, dose, and formulation; some states also add a synchronous-consult fee.
View complete program record
Editorial readout · checked September 4th, 2026
What the public record shows
The combination of no automatic renewal and pharmacy-level detail gives shoppers useful control. The lowest price is pharmacy- and state-dependent, and some states require a paid synchronous consultation.
Evidence score breakdown
Cost clarity24/25
Clinical accountability16/20
Medication + pharmacy20/20
Ongoing support13/15
Terms + states7/10
Evidence freshness10/10
Remaining published terms
Included care and support
Medication if prescribed, provider access, supplies, educational resources, and shipping are included; some states require a $25 synchronous consultation.
Coverage is pharmacy-specific. New Life/Hyalo is shown across all 50 states and Washington, DC, while the other pharmacy paths publish narrower state lists.
Orders do not renew automatically; patients reorder when they want to continue. A required synchronous visit adds $25, and an initial medical-screen rejection may be refunded less a $50 consultation fee.
Publishes compounded tirzepatide paths through Drug Crafters, ReviveRx, Mountain Care, White Label/Nova, and New Life/Hyalo, with formulation and state notes.
Hims publishes a required recurring membership, separate medication prices, and a broad menu of oral and injectable brand-name options in a messaging-led care model.
Published cost
$39 for the first membership month and $149 per month after that. Medication is purchased separately if prescribed; listed starting prices begin at $149 per month for selected options.
A licensed provider reviews the medical intake and determines whether treatment is appropriate. Members can message licensed providers, and treatment may be adjusted over time.
Hims lists several FDA-approved oral and injectable brand-name options and publishes medication-specific safety links. The required membership does not include or guarantee a prescription.
Readers who prefer an online intake and ongoing messaging and want several published brand-name medication formats to discuss with a licensed provider.
What to confirm
The $39 first month is not the ongoing price; the membership currently renews at $149 per month before medication.
View complete program record
Editorial readout · checked September 4th, 2026
What the public record shows
Hims makes the membership-plus-medication structure visible and lists several oral and injectable formats. State availability and the final medication price depend on the individual care path, so confirm both before enrolling.
Evidence score breakdown
Cost clarity24/25
Clinical accountability16/20
Medication + pharmacy16/20
Ongoing support14/15
Terms + states7/10
Evidence freshness10/10
Remaining published terms
Ongoing support
The membership advertises 24/7 Care Team access, licensed-provider messaging, dose adjustments, side-effect support, tracking tools, and an optional smart scale.
The current program pages present a direct-pay model and state that insurance is not required. HSA/FSA eligibility is described separately for medication and membership fees.
Treatment and medication access depend on the patient's state, clinical eligibility, and the options available through the prescribing and pharmacy network.
The membership auto-renews monthly after the first month. Hims says members can cancel, but canceling membership also ends active medication plans and platform care access.
WeightWatchers Med+ combines an affiliated medical group and insurance support with the WeightWatchers app, nutrition tools, workshops, community, and regular care-team check-ins.
Published cost
The site displayed a twelve-month Med+ offer at $25 per month for the first two months and $74 per month for the rest of the term. GLP-1 medication is not included. This offer was scheduled to end September 8th, 2026 and must be rechecked after that date.
Checked September 4th, 2026Offer ends September 8th, 2026[1][2]
Clinical accountability
Medical services are provided through the affiliated WeightWatchers Clinic. The published flow includes a telehealth consultation with a board-certified clinician who determines whether medication is appropriate.
WeightWatchers says Med+ prescribes FDA-approved medications only. Its public page names several possible GLP-1 options and says prescriptions may be delivered for some plans or sent to the patient's chosen pharmacy.
Readers who want clinician-guided care alongside structured nutrition, app, workshop, and community support and are comfortable evaluating a longer membership commitment.
What to confirm
The currently visible membership price is a limited-time offer tied to a twelve-month plan and expires shortly after this review date.
View complete program record
Editorial readout · checked September 4th, 2026
What the public record shows
Med+ publishes an extensive behavior-support system, but the price comparison needs care. GLP-1 medication is separate, and the membership price visible during this review was a time-limited twelve-month offer rather than a permanent month-to-month rate.
Evidence score breakdown
Cost clarity18/25
Clinical accountability18/20
Medication + pharmacy16/20
Ongoing support15/15
Terms + states8/10
Evidence freshness10/10
Remaining published terms
Ongoing support
Med+ includes regular Care Team check-ins, insurance coordination, personalized nutrition and fitness support, app tools, expert-led workshops, and community features.
The Care Team works on coverage, prior authorization, and refills. Coverage is not guaranteed, and a member may still owe a medication copay in addition to membership.
The price observed during this review required a twelve-month plan that automatically renews for another twelve-month period at the same monthly rate unless canceled.
Checked September 4th, 2026Offer ends September 8th, 2026[1][2][3]
Documented care path
01
Eligibility quiz
Submit health-history information to see whether the clinic may be a fit.
Gimme Care publishes simple one- and three-month prices for compounded semaglutide and tirzepatide with consultation, medication if prescribed, supplies, shipping, and portal support included.
Published cost
Semaglutide is $160 for one month or $130 per month on a three-month billing cycle. Tirzepatide is $199 for one month or $163 per month on a three-month billing cycle.
Publishes compounded semaglutide and tirzepatide programs from US pharmacies; the public offer pages do not identify the assigned pharmacy, formulation, concentration, or total milligrams. Compounded medications are not FDA-approved drug products.
Straightforward one- and three-month prices with consultation, medication, and support bundled
What to confirm
The public offer does not name the dispensing pharmacy or exact formulation before intake.
View complete program record
Editorial readout · checked September 4th, 2026
What the public record shows
The bundle is easy to budget and includes unlimited provider messaging. Before enrolling, confirm the assigned pharmacy, exact formulation, concentration, total milligrams, and three-month billing total.
Evidence score breakdown
Cost clarity24/25
Clinical accountability16/20
Medication + pharmacy10/20
Ongoing support15/15
Terms + states9/10
Evidence freshness10/10
Remaining published terms
Included care and support
Consultation, medication if prescribed, supplies, shipping, follow-ups, dose adjustments, unlimited messaging, and portal access are included.
The provider publishes service across all 50 states and Washington, DC. Kansas, Louisiana, Mississippi, New Mexico, and West Virginia require a brief audio or video visit.
Publishes compounded semaglutide and tirzepatide programs from US pharmacies; the public offer pages do not identify the assigned pharmacy, formulation, concentration, or total milligrams.
Brello Health bundles compounded semaglutide or tirzepatide with provider review, messaging, supplies, shipping, app access, classes, and community tools.
Published cost
Compounded semaglutide is $399 for the initial plan and renews for $399 every 11 weeks. Compounded tirzepatide is $499 initially and renews for $499 every 11 weeks.
A healthcare provider reviews the submitted health information and decides whether to prescribe. Approved patients can use provider messaging during the program.
Publishes compounded semaglutide and tirzepatide paths prepared by a US-based 503A pharmacy; confirm the assigned pharmacy, formulation, concentration, and vial plan before paying. Compounded medications are not FDA-approved drug products.
People who will use provider messaging, app tracking, classes, and community support
What to confirm
The monthly-equivalent headline is not the billing cadence; compare the actual $399 or $499 charge every 11 weeks.
View complete program record
Editorial readout · checked September 4th, 2026
What the public record shows
The included support is broader than a medication-only bundle. Compare the actual recurring charge and 11-week renewal cadence rather than relying on a monthly-equivalent headline.
Evidence score breakdown
Cost clarity22/25
Clinical accountability15/20
Medication + pharmacy9/20
Ongoing support14/15
Terms + states8/10
Evidence freshness10/10
Remaining published terms
Included care and support
Medication if prescribed, provider review and messaging, injection supplies, shipping, app access, classes, and community tools are included.
Brello's published map marks 39 states and Washington, DC, available. It marks Alabama, Arkansas, California, Connecticut, Indiana, Massachusetts, Michigan, Nevada, New Jersey, North Carolina, and South Carolina as not licensed.
Both programs have a three-month minimum. Semaglutide renews at $399 every 11 weeks and tirzepatide renews at $499 every 11 weeks until canceled under the published terms.
A healthcare provider reviews the submitted health information and decides whether to prescribe. Approved patients can use provider messaging during the program.
Publishes compounded semaglutide and tirzepatide paths prepared by a US-based 503A pharmacy; confirm the assigned pharmacy, formulation, concentration, and vial plan before paying.
Fifty 410 publishes bundled compounded semaglutide and tirzepatide prices, requires no card for intake, and requests payment only after a licensed provider issues a prescription.
Published cost
The detailed pricing page lists semaglutide at $199 for one month, while the homepage also promotes a $299 three-month semaglutide option. Tirzepatide is $399 for a three-month starter, $499 for the listed mid-dose tier, or $549 for the high-dose tier.
A licensed provider independently reviews the intake and decides whether a listed program is appropriate. Consultation and portal follow-up are included.
Publishes compounded semaglutide and tirzepatide programs prepared by independent compounding pharmacies; confirm the pharmacy assigned to an individual order before payment. Compounded medications are not FDA-approved drug products.
Starting clinical review without a card, subscription, or payment before a prescribing decision
What to confirm
The dispensing pharmacy and exact formulation are assigned through the individual prescription path rather than named in the public price grid.
View complete program record
Editorial readout · checked September 4th, 2026
What the public record shows
The no-membership, pay-after-prescription flow is unusually direct. Before paying, confirm the dispensing pharmacy, formulation, and state availability for the prescribed path.
Evidence score breakdown
Cost clarity24/25
Clinical accountability15/20
Medication + pharmacy8/20
Ongoing support12/15
Terms + states6/10
Evidence freshness10/10
Remaining published terms
Included care and support
The bundle includes licensed-provider consultation, medication if prescribed, portal follow-up, refrigerated packaging, and overnight or two-day shipping.
Fifty 410 collects the patient's state at intake. Care is available only when the treating provider is licensed or otherwise authorized in the patient's physical state, with required state-specific consent presented in the portal.
There is no subscription or automatic renewal. Published semaglutide choices cover one or three months, while listed tirzepatide choices cover three months and ship upfront after payment. A paid order is refundable only before compounding begins.
A licensed provider independently reviews the intake and decides whether a listed program is appropriate. Consultation and portal follow-up are included.
Publishes compounded semaglutide and tirzepatide programs prepared by independent compounding pharmacies; confirm the pharmacy assigned to an individual order before payment.
Published semaglutide choices cover one or three months and tirzepatide choices cover three months. Prescribed medication ships upfront after payment, with portal follow-up included.
Good Life Meds publishes separate compounded semaglutide and tirzepatide paths, including a detailed 12-week tirzepatide starter sequence and continuing-plan totals.
Published cost
Compounded semaglutide is listed at $199 monthly. Tirzepatide is $599 for the 12-week starter sequence, then $297 monthly, $822 quarterly, or $1,494 for six months.
A licensed provider reviews the online intake and decides whether to prescribe. Clinician consultation and portal access for ongoing care are included.
Publishes separate compounded semaglutide and tirzepatide offers through US-licensed pharmacies; confirm the dispensing pharmacy and exact assigned formulation before payment. Compounded medications are not FDA-approved drug products.
A recurring semaglutide price or a clearly described tirzepatide starter sequence
What to confirm
The site advertises no membership requirement while its treatment pages describe automatically renewing subscriptions.
View complete program record
Editorial readout · checked September 4th, 2026
What the public record shows
The starter sequence and included services are clearly described. Budget from the recurring-plan language, and confirm the dispensing pharmacy and formulation before payment.
Evidence score breakdown
Cost clarity21/25
Clinical accountability15/20
Medication + pharmacy8/20
Ongoing support13/15
Terms + states7/10
Evidence freshness10/10
Remaining published terms
Included care and support
Medication if prescribed, clinician consultation, ongoing care, injection supplies, expedited shipping, and portal access are included.
The semaglutide program renews monthly. Tirzepatide offers include a 12-week starter followed by monthly, quarterly, or six-month continuing choices. Subscriptions renew at the selected interval unless canceled before the next billing date; processed prescription charges are final.
A licensed provider reviews the online intake and decides whether to prescribe. Clinician consultation and portal access for ongoing care are included.
Publishes separate compounded semaglutide and tirzepatide offers through US-licensed pharmacies; confirm the dispensing pharmacy and exact assigned formulation before payment.
Confirm the assigned pharmacy, formulation, next shipment, and renewal date before payment; cancel before the next bill because processed prescription charges are final.
Pomegranate Health's live pricing interface displays starter paths for compounded semaglutide and tirzepatide, selected formulations, pharmacies, term choices, and location surcharges.
Published cost
The current starter view shows semaglutide plus B12 at $119 per month with one-, two-, four-, or six-month terms, and tirzepatide plus B6 at $149 per month with one- or two-month terms.
Telehealth clinicians may include physicians, nurse practitioners, and physician assistants. A clinician reviews eligibility and retains discretion over prescribing and pharmacy routing.
The app displays semaglutide plus B12 with Empower selected and tirzepatide plus B6 with BPI selected. Subscription terms state that pharmacy assignment is not guaranteed. Compounded medications are not FDA-approved drug products.
Seeing starter formulation, selected pharmacy, term choices, and location surcharge together
What to confirm
The displayed pharmacy is not guaranteed, and requesting a specific pharmacy can add a $150 coordination fee.
View complete program record
Editorial readout · checked September 4th, 2026
What the public record shows
The configurator is useful for seeing the starting choice. The separate subscription terms matter: pharmacy assignment is not guaranteed, a requested pharmacy can add a coordination fee, and listed charges are generally nonrefundable.
Evidence score breakdown
Cost clarity18/25
Clinical accountability15/20
Medication + pharmacy14/20
Ongoing support10/15
Terms + states7/10
Evidence freshness10/10
Remaining published terms
Included care and support
The configurator presents a bundled starter path; save the final summary showing consultation, medication, shipping, term, and any pharmacy-coordination charge.
Pomegranate says its platform serves all 50 states, Puerto Rico, and Guam. Medication remains jurisdiction-specific, and the pricing app adds a $60 shipping surcharge for Alaska, Hawaii, and Puerto Rico.
The selected plan renews automatically unless canceled at least 24 hours before the period ends. Listed medication, membership, and one-time consultation charges are generally nonrefundable.
Telehealth clinicians may include physicians, nurse practitioners, and physician assistants. A clinician reviews eligibility and retains discretion over prescribing and pharmacy routing.
The app displays semaglutide plus B12 with Empower selected and tirzepatide plus B6 with BPI selected. Subscription terms state that pharmacy assignment is not guaranteed.
Direct pay · compounded semaglutide, tirzepatide, and liraglutide
Evidence73/100
CosmeticRx publishes monthly compounded semaglutide, tirzepatide, and liraglutide paths with clinician review, ongoing online care, and shipping.
Published cost
The public weight-loss page lists compounded semaglutide at $179 per month, tirzepatide at $299 per month, and liraglutide at $499 per month, with shipping included.
The official catalog identifies compounded formulation records, while the consumer path requires confirmation of the exact formulation and dispensing pharmacy assigned to the prescription. Compounded medications are not FDA-approved drug products.
Reviewing possible compounded semaglutide, tirzepatide, and liraglutide formulations
What to confirm
The consumer path still requires confirmation of the exact formulation, concentration, total milligrams, and dispensing pharmacy assigned to the prescription.
View complete program record
Editorial readout · checked September 4th, 2026
What the public record shows
Its provider-owned catalog exposes more formulation records than the landing page alone. Confirm which formulation, concentration, total milligrams, and dispensing pharmacy apply before enrollment.
Evidence score breakdown
Cost clarity19/25
Clinical accountability15/20
Medication + pharmacy12/20
Ongoing support11/15
Terms + states6/10
Evidence freshness10/10
Remaining published terms
Included care and support
Online clinician review, ongoing care, medication if prescribed, and shipping are included in the public weight-loss program.
Service is limited to adults age 18 or older in US locations where CosmeticRx operates and a participating clinician may legally prescribe. Prescriptions may be sent locally or fulfilled through a mail-order pharmacy network.
GLP-1 prices are shown per month. Terms authorize recurring payments and allow future shipments to be canceled, while a prescription product that has shipped cannot be returned.
The official catalog identifies compounded formulation records, while the consumer path requires confirmation of the exact formulation and dispensing pharmacy assigned to the prescription.
The consumer path still requires confirmation of the exact formulation, concentration, total milligrams, and dispensing pharmacy assigned to the prescription.
Direct pay · compounded and brand-name GLP-1 paths
Evidence73/100
FitnessRx publishes compounded semaglutide and tirzepatide paths alongside brand-name program options and bundles its Body FX app with behavioral coaching.
Published cost
Standard compounded tirzepatide and oral compounded semaglutide each start at $149 for the introductory month and list $279 monthly after. Tirzepatide micro starts at $119 and lists $199 monthly after; brand-name paths have separate cash prices.
Publishes compounded and brand-name GLP-1 paths. The compared compounded page does not identify the pharmacy; an FDA Green List reference is not approval of the provider, pharmacy, or finished compounded drug. Compounded medications are not FDA-approved drug products.
App-based fitness and behavioral coaching alongside compounded or brand-name treatment paths
What to confirm
The introductory price changes after the first month, so compare the ongoing monthly rate before enrolling.
View complete program record
Editorial readout · checked September 4th, 2026
What the public record shows
The coaching layer is the differentiator. Budget from the ongoing price after the introductory month and confirm the medication path, pharmacy, shipping charge, and renewal timing.
Evidence score breakdown
Cost clarity20/25
Clinical accountability14/20
Medication + pharmacy8/20
Ongoing support14/15
Terms + states7/10
Evidence freshness10/10
Remaining published terms
Included care and support
The Body FX app, daily behavioral coaching, provider guidance, community features, and scheduling tools are included with the compared program paths.
Enrollment is limited to US residents age 18 or older. Treatment availability requires medical approval and a valid prescription from a licensed provider.
Plans bill monthly as recurring subscriptions. Cancellation is available through the account dashboard and takes effect at the end of the current billing cycle. The landing page says free shipping, while the terms allow a $5 to $20 shipping charge at checkout.
Publishes compounded and brand-name GLP-1 paths. The compared compounded page does not identify the pharmacy; an FDA Green List reference is not approval of the provider, pharmacy, or finished compounded drug.
Oak publishes clinician-reviewed compounded semaglutide and tirzepatide paths, with free shipping, health coaching, and Care Team access advertised.
Published Cost
Oak's homepage says programs start as low as $119 per month, while its weight-loss page says programs start at $190 per month. Neither page publishes one complete medication- and dose-specific price table.
A licensed clinician through an independent medical-group partner reviews the online intake and decides whether to prescribe. Oak says asynchronous review is available, although a clinician may request a video visit.
Oak markets compounded semaglutide and compounded tirzepatide, with B6 or B12 options when appropriate. Its terms describe fulfillment through an Oak partner-pharmacy network but do not name the patient's assigned dispensing pharmacy.
Cash-pay shoppers considering Oak's compounded semaglutide or tirzepatide paths who will confirm the complete charge, recurring setting, state eligibility, and dispensing pharmacy before paying.
What to confirm
Starting prices conflict across Oak's public pages, and no medication- and dose-specific price table is published; confirm the complete charge before authorizing payment.
View complete program record
Editorial readout · checked September 4th, 2026
What the public record shows
Oak identifies the compounded ingredients it markets and explains its online review sequence. Its public record is less clear on complete cost and fulfillment: the homepage and weight-loss page publish different starting figures, its terms say most prescriptions recur, and no dispensing pharmacy is named before intake.
Evidence score breakdown
Cost clarity14/25
Clinical accountability15/20
Medication + pharmacy13/20
Ongoing support12/15
Terms + states6/10
Evidence freshness10/10
Remaining published terms
Ongoing Support
Oak advertises Care Team access, health coaching, clinician messaging, dose review, shipment tracking, and free standard shipping during active treatment.
Oak's terms say the service operates in 45 states and direct readers to its FAQ for the current eligible-state list. Medication, clinician, and pharmacy availability remain patient- and location-specific.
Oak marketing advertises no hidden membership fee and no long-term commitment. Its terms say most prescriptions are recurring subscriptions and that approved orders are nonrefundable once sent for fulfillment.
Starting prices conflict across Oak's public pages, and no medication- and dose-specific price table is published; confirm the complete charge before authorizing payment.
The cheapest headline can describe a completely different service.
We rank disclosure across care models, then label the exact path reviewed. That keeps a direct-pay compounded package from masquerading as the same thing as an insurance-supported brand-name program.
3
Insurance-supported
Membership or care fee plus the separate cost of an FDA-approved prescription. Prior-authorization help can matter more than the lowest advertised fee.
A cash package may include the consultation, prescription if appropriate, medication, supplies, and shipping. Pharmacy and formulation disclosure become central.
These services publish both compounded and FDA-approved routes. The patient-specific cost still depends on the selected medication and fulfillment path.
Confirm the charge date, commitment length, auto-renewal setting, cancellation deadline, and which payments are refundable.
Record: term · charge date · renewal · cancellation · refund
100-point evidence model
Six questions, fixed weights
External ratings, testimonials, popularity, and complaints never contribute points to an evidence score.
25
Cost clarity
Membership, medication, fees, and commitment
20
Clinical accountability
Who reviews eligibility and remains available
20
Medication + pharmacy
Drug status, pharmacy path, and fulfillment
15
Ongoing support
Follow-up, messaging, labs, and care cadence
10
Terms + states
Availability, renewals, and insurance limits
10
Evidence freshness
How recently every scoring source was checked
Use the ranking carefully
A higher score means more of the offer is documented.
It does not mean a treatment is right for you. Eligibility, contraindications, drug choice, dose, and monitoring belong to a licensed clinician. Before paying, confirm today’s total cost, prescribing entity, dispensing pharmacy, state availability, cancellation rules, and included follow-up.
Lavender Sky Health ranks first in our September 4th, 2026 evidence review because its public pages answer the greatest share of our cost, clinical, medication, pharmacy, support, availability, and commitment questions. The score measures disclosure—not medical quality, safety, or likely results.
Are all online GLP-1 provider programs directly comparable?+
No. Some programs coordinate insurance for FDA-approved medication, some publish direct-pay compounded paths, and some support both. Compare the care path and medication status before comparing price because a membership fee, cash package, and medication copay are different charges.
Does the highest evidence score mean a provider is medically best?+
No. The score rewards current public answers and clear terms. It does not rate clinical quality, medication safety, outcomes, popularity, or suitability for an individual patient.
What should I confirm before paying an online GLP-1 provider?+
Confirm the total charge due now, medication status, prescribing entity, dispensing pharmacy when applicable, state eligibility, follow-up access, renewal timing, and cancellation or refund terms. A licensed clinician must decide whether treatment is appropriate.
Supplemental primary guidance
FDA checks used across this ranking
Provider-controlled evidence stays attached to its provider record. These sources cover the regulatory and pharmacy checks that apply across the comparison.
